Diabetic ketoacidosis

References

• Felig P. Diabetic ketoacidosis. N Engl J Med 1974; 290: 1360–3
   PubMed Web of Science ®Google Scholar
• Sherwin RS. Low-dose insulin therapy in diabetic ketoacidosis: a valid physiological approach, not a panacea. (Editorial) Arch Intern Med 1977; 137: 1361–2
   PubMedGoogle Scholar
• Kreisberg RA. Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. Ann Intern Med 1978; 88: 681–95
   PubMed Web of Science ®Google Scholar
• Harwood R. Diabetic ketoacidosis. N Engl J Med 1951; 245: 1–9
   PubMed Web of Science ®Google Scholar
• Skillman TG, Wilson R, Knowles HC Jr. Mortality of patients with diabetic ketoacidosis in a large city hospital. Diabetes 1958; 7: 109–13
   PubMed Web of Science ®Google Scholar
• Fitzgerald MG, O'Sullivan DJ, Matins JM. Fatal diabetic ketosis. Br Med J 1961; 1: 247–50
   PubMed Web of Science ®Google Scholar
• Beigelman PM. Severe diabetic ketoacidosis (diabetic “coma”): 482 episodes in 257 patients; experience of three years. Diabetes 1971; 20: 490–500
   PubMed Web of Science ®Google Scholar
• Soler NG, Bennett MA, Fitzgerald MG, et al. Intensive care in the management of diabetic ketoacidosis. Lancet 1973;1: 951–4
   PubMed Web of Science ®Google Scholar
• Keller U, Berger W, Ritz R, et al. Course and prognosis of 86 episodes of diabetic coma: a five year experience with a uniform schedule of treatment. Diabetologia 1975; 11: 93–100
   PubMed Web of Science ®Google Scholar
• Alberti KG. Diabetic ketoacidosis: aspects of management. In: Ledingham JG, ed. 10th Advanced Medicine Symposium. New York: Fearon-Pitman Publishers, 1974: 68–82
   Google Scholar
• Matz R. Diabetic coma: guidelines in therapy. NY State J Med 1974;74: 642–8
   PubMedGoogle Scholar
• Kitabchi AE, Aryyagari V, Guerra SM, et al. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med 1976; 84: 633–8
   PubMed Web of Science ®Google Scholar
• Bendezu R, Wieland RG, Furst BH, et al. Experience with low-dose insulin infusion in diabetic ketoacidosis and diabetic hyperos-molarity. Arch Intern Med 1978; 138: 60–2
   PubMedGoogle Scholar
• Knight AH, Williams DN, Ellis G, et al. Significance of hyperamylasaemia and abdominal pain in diabetic ketoacidosis. Br J Med 1973; 3: 128–31
   PubMed Web of Science ®Google Scholar
• Vinicor F, Lerner LM, Karn RC, et al. Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med 1979;91: 200–4
   PubMed Web of Science ®Google Scholar
• Clements RN Jr. Ketoacidosis. South Med J 1976: 69: 217–21
   PubMed Web of Science ®Google Scholar
• Soler NG, Bennett MA, Fitzgerald MG, et al. Electrocardiogram as a guide to potassium replacement in diabetic ketoacidosis. Diabetes 1974; 23: 610–5
   PubMed Web of Science ®Google Scholar
• Amnion RA, May WS, Nightingale SD, et al. Glucose-induced hyperkalemia with normal aldosterone levels: studies in a patient with diabetes mellitus. Ann Intern Med 1978; 89: 349–51
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Sherwin RS, Felig P, et al. Nonuremic diabetic hyperkalemia: possible role of insulin deficiency. Arch Intern Med 1977; 137: 842–3
   PubMedGoogle Scholar
• Oster JR, Perez GO, Vaamonde CA. Relationship between blood pH and potassium and phosphorus during acute metabolic acidosis. Am J Physiol 1978; 4: F345–51
   Google Scholar
• Oh MS, Carroll HJ, Goldstein DA, et al. Hyperchloremic acidosis during the recovery phase of diabetic ketosis. Ann Intern Med 1978; 89: 925–7
   PubMed Web of Science ®Google Scholar
• Daughaday WH, Lipicky RJ, Rasinski DC, et al. Lactic acidosis as a cause of nonketotic acidosis in diabetic patients. N Engl J Med 1962; 267: 1010–4
   PubMed Web of Science ®Google Scholar
• Miller PD, Heinig RE, Waterhouse C. et al. Treatment of alcoholic acidosis: the rote of dextrose and phosphorus. Arch Intern Med 1978; 138: 67–72
   PubMedGoogle Scholar
• Alexander WD, Oake RJ. The effect of insulin on vascular reactivity to norepinephrine. Diabetes 1977; 26: 611–4
   PubMed Web of Science ®Google Scholar
• Duck SC, Weldon VV, Pagliara AS, et al. Cerebral edema complicating therapy for diabetic ketoacidosis. Diabetes 1976; 25: 111–5
   PubMed Web of Science ®Google Scholar
• Guisado R, Arieff AI. Neurologic manifestations of diabetic comas: correlation with biochemical alterations in the brain. Metabolism 1975; 24: 665–79
   PubMed Web of Science ®Google Scholar
• Beigelman PM. Potassium in severe diabetic ketoacidosis. Am J Med 1973; 54: 419–20
   PubMed Web of Science ®Google Scholar
• Assal JP, Aoki TT, Manzano FM, et al. Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes 1974; 23: 405–11
   PubMed Web of Science ®Google Scholar
• Kanter Y, Gerson JR, Bessman AN, et al. 2,3-Diphosphoglycerate, nucleotide phosphate, and organic and inorganic phosphate levels during the early phases of diabetic ketoacidosis. Diabetes 1977; 26: 429–33
   PubMed Web of Science ®Google Scholar
• Cuthbert C, Alberti KG. Acidemia and insulin resistance in the diabetic ketoacidotic rat. Metabolism (12 Suppl 2) 1978; 27: 1903–16
   Google Scholar
• Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 1977; 137; 203–20
   PubMed Web of Science ®Google Scholar
• Kreisberg RA. Phosphorus deficiency and hypophosphatemia. Hosp Pract 1977; 12(3): 121–8
   PubMed Web of Science ®Google Scholar
• McGarry JD, Foster DW. Hormonal control of ketogenesis: biochemical considerations. Arch Intern Med 1977; 137: 495–501
   PubMedGoogle Scholar
• Schade DS, Eaton RP. Pathogenesis of diabetic ketoacidosis: a reappraisal. Diabetes Care 1979; 2: 296–306
   PubMed Web of Science ®Google Scholar
• Keller U, Chiasson JL, Liljenquist JE, et al. The roles of insulin, glucagon, and free fatty acids in the regulation of ketogenesis in dogs. Diabetes 1977; 26: 1040–51
   PubMed Web of Science ®Google Scholar
• Raskin P, Fujita Y, Unger RH, et al. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. J Clin Invest 1975; 56: 1132–8
   PubMed Web of Science ®Google Scholar
• Shichiri M, Kawamori R, Abe H, et al. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes 1979; 28: 272–5
   PubMed Web of Science ®Google Scholar
• Lundbaek K, Hansen AP, Orskow H, et al. Failure of somatostatin to correct manifest diabetic ketoacidosis. Lancet 1976; 1: 215–8
   PubMed Web of Science ®Google Scholar
• Alberti KG. Low-dose insulin in the treatment of diabetic ketoacidosis. Arch Intern Med 1977; 137: 1367–76
   PubMedGoogle Scholar
• Fisher JN, Shahshahani MN, Kitabchi AE, et al. Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med 1977; 297: 238–41
   PubMed Web of Science ®Google Scholar
• Kolterman OG, Insel J, Saekow M, et al. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 1980; 65: 1272–84
   PubMed Web of Science ®Google Scholar
• Padilla AJ, Loeb JN. ‘Low-dose’ versus ‘high-dose’ insulin regimens in the management of uncontrolled diabetes: a survey. Am J Med 1977; 63: 843–8
   PubMed Web of Science ®Google Scholar